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Abstract: Chylothorax is a serious complication of congenital cardiac surgery and is significantly associated with increased   morbidity 
and mortality. Central venous obstruction, which is often related to the insertion of central venous catheters for postoperative 
  management, is known to be an important risk factor for treatment failure and mortality associated with this condition. We present the 
case of a 6-month-old girl with refractory chylothorax after surgical repair of tetralogy of Fallot. The chylous drainage continued for 
more than 2 months despite maximal conservative therapy (water restriction, total parenteral nutrition, and infusion of somatostatin 
and steroid) and surgical ligation of the thoracic duct. Subsequently, we observed stenosis of the superior vena cava (SVC) caused 
by large thrombi possibly associated with the prolonged use of central venous catheter placed in the internal jugular vein. Because 
transcatheter balloon dilation failed to relieve the stenosis, we performed stent implantation for the SVC and innominate vein. After 
the procedure, chylous drainage dramatically reduced, and the patient was discharged from the hospital. In conclusion, central venous 
obstruction due to thrombosis should be routinely examined when chylothorax is diagnosed and is resistant to conservative therapy 
after congenital heart surgery. Stent implantation can effectively relieve the venous obstruction and thus be a life-saving treatment 
option for this difficult condition.
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Introduction
Chylothorax is an infrequent but a serious   complication 
of pediatric cardiovascular surgery and could often 
jeopardize  postoperative  recovery.  The  incidence 
of this condition has been increasing over the past 
decades, possibly due, in part, to the increased com-
plexity of cardiac surgery.1 Central venous obstruc-
tion, which is often related to the insertion of central 
venous catheters for postoperative management,2,3 is 
known to be an important risk factor for treatment 
failure and mortality associated with this condition.4–7 
In this report, we present the case of an infant with 
prolonged  chylothorax  associated  with  thrombosis 
or obstruction of the superior vena cava (SVC). The 
chylothorax was resistant even to thoracic duct liga-
tion performed after maximal conservative therapy. 
However,  stent  implantation for  the  SVC  dramati-
cally resolved the chylous drainage.
Case report
The patient was a 6-month-old girl with a small right 
ventricle (70% of normal) who underwent surgical 
correction of tetralogy of Fallot. She had postopera-
tive heart failure represented by low cardiac output 
and elevated central venous pressure of 13 mmHg. 
She  presented  with  massive  pleural  drainage  from 
postoperative day 1. Examination of the drained fluid 
revealed cell counts of 4,250 cells/µL with a predom-
inant lymphocyte fraction of 99%. The triglyceride 
levels were as high as 144 mg/dL, which confirmed 
that she had chylothorax. Because the chylous drain-
age did not reduce with the generally recommended 
conservative  therapy,  including  water  restriction 
(60 mL ⋅ kg−1 ⋅ day−1) and total parenteral nutrition, 
we  initiated  administration  of  a  somatostatin  ana-
logue at a dose of 10 µg ⋅ kg−1 ⋅ h−1 on postoperative 
day 7. Nonetheless, chylous drainage persisted, and 
thoracic duct ligation was performed on postopera-
tive day 35. Although chylous drainage temporarily 
decreased after the surgery, it did not stop completely 
and increased gradually while supportive therapies, 
including water restriction, total parenteral nutrition, 
and somatostatin analogue infusion, were continued. 
Steroid  administration  was  also  ineffective.  An 
echocardiogram  on  postoperative  day  70  revealed 
stenosis of the SVC due to large thrombi (Fig. 1). 
A central venous catheter had been placed in the right 
internal jugular vein from postoperative day 0 to 10 
and from day 28 to 58. An important observation was 
that there was an unexpected decrease in the platelet 
count from 444 × 103/µL on postoperative day 44 to 
152 × 103/µL on postoperative day 54. Balloon dila-
tion for the SVC stenosis performed on postoperative 
day 80 (Fig. 2) only temporarily and partially reduced 
the  chylous  drainage. The  chylous  drainage  began 
to increase 1 week after the procedure. Thrombosis 
developed despite the administration of tissue plas-
minogen activator followed by continuous infusion of 
heparin. Therefore, we performed stent implantation 
in the SVC (Express LD 8 mm × 27 mm) and innomi-
nate vein (Express LD 7 mm × 17 mm) on postopera-
tive day 102 (Fig. 3). Stent implantation dramatically 
reduced the chylous drainage from 40 ml ⋅ kg−1 ⋅ d−1 to 
3.5 ml ⋅ kg−1 ⋅ d−1 (averaged during the 5 days before 
and after the procedure). The chest tube was success-
fully removed, and the patient was finally discharged 
from the hospital with diuretics and dietary control 
with milk enriched with medium-chain triglycerides.
Figure 1. Two-dimensional transthoracic echocardiography showing the large-sized thrombus (arrows). Four-chamber view in the left and superior vena 
cava seen in the right atrial view in the right.Stenting for chylothorax
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Discussion
Chylothorax  is  a  serious  complication  of  cardiac 
surgery and is associated with increased mortality. 
Because the thoracic duct enters the venous system 
at  angulus  venosus,  central  venous  obstruction  in 
the upper body and/or high central venous pressure 
inevitably causes resistance to the flow of the lymph 
into the venous system, which leads to congestion 
of the lymph thus resulting in chylous drainage into 
the pleural space.8,9 This pathophysiology is directly 
linked  to  the  well-recognized  clinical  finding  that 
central  venous  obstruction  and/or  high  central 
venous pressure is often associated with prolonged 
high volume of chylous drainage and is a significant 
risk factor for treatment failure.4–7,10 Central venous 
catheterization  required  for  administration  of 
medication  or  parenteral  nutrition  after  cardiac 
surgery  is  known  to  be  an  important  cause  of 
central  venous  thrombosis.2,3,11  Once  chylothorax 
develops,  prolonged  chylous  drainage,  in  turn, 
necessitates the use of a central venous catheter for 
a prolonged period for parenteral nutrition, which 
potentially leads to a viscous cycle of thrombosis 
formation and chylous drainage. Antithrombin lost 
in  chyle2,12  and/or  vascular  inflammation  induced 
by hyperalimentation solution2 may also contribute 
to  increased  susceptibility  for  the  development  of 
thrombosis in patients with chylothorax.
In our patient, chylothorax developed soon after 
surgery, which suggested that operative injury to the 
thoracic duct was the primary cause of chylothorax.1 
Elevated central venous pressure possibly associated 
with  an  underdeveloped  right  ventricle  could  have 
further accelerated and prolonged the chylous drainage. 
Figure 2. Transcatheter balloon dilation of the superior vena cava (SVC). Note that the lumen of the SVC remained irregular after the procedure, indicating 
incomplete relief of the stenosis.
Figure 3. Stent implantation in the superior vena cava. Angiographic defects due to thrombi-induced stenosis (indicated by arrows in the left panel) were 
completely resolved after the stent implantation (right).Tamai et al
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Formation of venous thrombosis was also believed 
to  have  contributed  significantly  to  the  refractory 
chylous drainage observed even after thoracic duct 
ligation,  because  chylothorax  resolved  after  the 
venous obstruction was relieved by stent implantation. 
Nath et al reported an important finding that although 
the overall outcome of surgical thoracic duct ligation 
for  chylothorax  refractory  to  conservative  medical 
therapy is excellent, patients with upper body venous 
thrombosis were at a high risk of treatment failure and 
mortality.7 Considering the clinical course and the huge 
size of the thrombus formed in our patient, it might be 
assumed that the process of thrombus formation might 
have started much earlier than we recognized it. Thus, 
the findings in our patient and those in previous reports 
indicate the importance of high index of suspicion for 
central venous thrombosis and obstruction, especially 
in patients with refractory chylothorax. A decrease in 
platelet count, as observed in our patient, and possibly 
an  increase  in  the  level  of  D-dimers  may  provide 
useful information for this purpose.
Conventionally, surgical intervention is indicated 
when conservative therapy fails to control the lym-
phatic  leak;  however,  specific  and  precise  criteria 
for  abandoning  conservative  therapy  remain  to  be 
standardized.1,6,11 A consensus for treatment of chy-
lothorax  with  central  venous  stenosis/occlusion 
remains to be established. To our knowledge, this is 
the first report on stent implantation for stenosis of 
the SVC due to thrombosis for effective treatment 
of  otherwise  uncontrollable  chylothorax  after  con-
genital cardiac surgery. Our findings are in line with 
those reported in an infant born with congenital SVC 
obstruction in whom successful placement of an intra-
vascular stent led to the resolution of the chylothorax 
with  rapid  clinical  improvement.13  Balloon  angio-
plasty can be an alternative to stent implantation, but 
in our patient, the treatment efficacy of stenting was 
greater than that of balloon dilation. Administration 
of anticoagulants or thrombolytics may be effective 
in  some  patients  with  chylothorax  associated  with 
thrombosis,3,11  but  these  drugs  were  ineffective  in 
our patient.
conclusion
Central venous thrombosis and resultant venous stenosis/ 
occlusion  can  cause  a  life-threatening  refractory 
  chylothorax  after  congenital  heart  surgery.  Stent 
  implantation  can  effectively  relieve  the  venous 
obstruction and thus be a life-saving treatment option 
for this   difficult condition. Early diagnosis and interven-
tion may lead to early recovery and eliminate unnec-
essary treatments. Thus, physicians should maintain a 
high index of   suspicion for venous obstruction when 
chylothorax is diagnosed and is resistant to conserva-
tive therapy.
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